Homeostatic housecleaning effect of selenium: Evidence that noncytotoxic oxidant-induced damage sensitizes prostate cancer cells to organic selenium-triggered apoptosis

BioFactors

Volumn 39, Issue 5, 2013, Pages 575-588

  Chiang, Emily C ^a,b   Bostwick, David G ^c   Waters, David J ^a,b,d  

^a PURDUE UNIVERSITY   (United States)

^b Gerald P Murphy Cancer Foundation   (United States)

^c BOSTWICK LABORATORIES   (United States)

^d PURDUE UNIVERSITY   (United States)

Author keywords

Cell fate; Chemoprevention; Damage response; Oxidative stress

Indexed keywords

4 (4 FLUOROPHENYL) 2 (4 NITROPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; ANTINEOPLASTIC AGENT; DOUBLE STRANDED DNA; ETOPOSIDE; HYDROGEN PEROXIDE; METHYLSELENINIC ACID; MITOGEN ACTIVATED PROTEIN KINASE; SELENIUM; UNCLASSIFIED DRUG; ZINOSTATIN;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PREVENTION; CANINE MODEL; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA STRAND BREAKAGE; DRUG EFFECT; DRUG EXPOSURE; ENZYME ACTIVATION; HOMEOSTASIS; HUMAN; HUMAN CELL; IN VITRO STUDY; NONHUMAN; PRIORITY JOURNAL; PROSTATE CANCER; SENSITIZATION;

CANIS FAMILIARIS;

CELL FATE; CHEMOPREVENTION; DAMAGE RESPONSE; OXIDATIVE STRESS;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; CELL LINE, TUMOR; CELL PROLIFERATION; DNA DAMAGE; DNA REPAIR; DOGS; ETOPOSIDE; HOMEOSTASIS; HUMANS; HYDROGEN PEROXIDE; MALE; MUTAGENS; ORGANOSELENIUM COMPOUNDS; OXIDANTS; PROSTATIC NEOPLASMS; ZINOSTATIN;

EID: 84886395043     PISSN: 09516433     EISSN: 18728081     Source Type: Journal    
DOI: 10.1002/biof.1106     Document Type: Article

References (51)

1. Allaway, W. H., Kubota, J., Losee, F., and Roth, M. (1968) Selenium, molybdenum, and vanadium in human blood. Arch. Environ. Health 16, 342-348.
2. Clark, L. C., Combs, G. F. Jr, Turnbull, B. W., Slate, E. H., Chalker, D. K., Chow, J., Davis, L. S., Glover, R. A., Graham, G. F., Gross, E. G., Krongard, A., Lesher, J. L. Jr, Park, H. K., Sanders, B. B. Jr, Smith, C. L., and Taylor, J. R. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. JAMA 276, 1957-1963.
3. Jiang, W., Jiang, C., Pei, H., Wang, L., Zhang, J., Hu, H., and Lü, J. (2009) In vivo molecular mediators of cancer growth suppression and apoptosis by selenium in mammary and prostate models: lack of involvement of gadd genes. Mol. Cancer Ther. 8, 682-691.
4. Li, G. X., Lee, H. J., Wang, Z., Hu, H., Liao, J. D., Watts, J. C., Combs, G. G. Jr, and Lü, J. (2008) Superior in vivo inhibitory efficacy of methylseleninic acid against human prostate cancer over selenomethionine or selenite. Carcinogenesis 29, 1005-1012.
5. Wang, Z., Hu, H., Li, G., Lee, H. J., Jiang, C., Kim, S. H., and Lü, J. (2008) Methylseleninic acid inhibits microvascular endothelial G1 cell cycle progression and decreases tumor microvessel density. Int. J. Cancer 122, 15-24.
6. Ip, C., and Ganther, H. E. (1988) Efficacy of trimethylselenonium versus selenite in cancer chemoprevention and its modulation by arsenite. Carcinogenesis 9, 1481-1484.
7. Ip, C., Thompson, H. J., Zhu, Z., and Ganther, H. E. (2000) In vitro and in vivo studies of methylseleninic acid: evidence that a monomethylated selenium metabolite is critical for cancer chemoprevention. Cancer Res. 60, 2882-2886.
8. Wang, L., Bonorden, M. J., Li, G. X., Lee, H. J., Hu, H., Zhang, Y., Liao, J. D., Cleary, M. P. and Lü, J. (2009) Methyl-selenium compounds inhibit prostate carcinogenesis in the transgenic adenocarcinoma of mouse prostate model with survival benefit. Cancer Prev. Res. 2, 484-495.
9. Zeng, H., Davis, C. D., and Finley, J. W. (2003) Effect of selenium-enriched broccoli diet on differential gene expression in min mouse liver. J. Nutr. Biochem. 14, 227-231.
10. Hu, Y., McIntosh, G. H., Le Leu, R. K., Woodman, R., and Young, G. P. (2008) Suppression of colorectal oncogenesis by selenium-enriched milk protein: apoptosis and K-ras mutations. Cancer Res. 68, 4936-4944.
11. Das, R. K., Hossain, S. K., and Bhattacharya, S. (2005) Diphenylmethyl selenocyanate inhibits DMBA-croton oil induced two-stage mouse skin carcinogenesis by inducing apoptosis and inhibiting cutaneous cell proliferation. Cancer Lett. 230, 90-101.
12. Waters, D. J., Shen, S., Cooley, D. M., Bostwick, D. G., Qian, J., Combs, G. F. Jr, Glickman, L. T., Oteham, C., Schlittler, D., and Morris, J. S. (2003) Effects of dietary selenium supplementation on DNA damage and apoptosis in canine prostate. J. Natl. Cancer Inst. 95, 237-241.
13. Waters, D. J., Shen, S., Glickman, L. T., Cooley, D. M., Bostwick, D. G., Qian, J., Combs, G. G. Jr, and Morris, J. S. (2005) Prostate cancer risk and DNA damage: translational significance of selenium supplementation in a canine model. Carcinogenesis 26, 1256-1262.
14. Waters, D. J., Chiang, E. C., and Bostwick, D. G. (2008) The art of casting nets: fishing the prize of personalized cancer prevention. Nutr. Cancer 60, 1-6.
15. Singh, N. P., McCoy, M. T., Tice, R. R., and Schneider, E. L. (1988) A simple technique for quantitation of low levels of DNA damage in individual cells. Exp. Cell Res. 175, 184-191.
16. 125IdUrd. Int. J. Radiat. Biol. 64, 349-358.
17. Collins, A. R., Ma, A. G., and Duthie, S. J. (1995) The kinetics of repair of DNA damage (strand breaks and oxidized pyrimidines) in human cells. Mutat. Res. 336, 69-77.
18. Yang, G., Yin, S., Zhou, R., Gu, L., Yan, B., Liu, Y., and Liu, Y. (1989) Studies of safe maximal daily dietary Se-intake in seleniferous area in China. Part II: Relation between Se-intake and the manifestation of clinical signs and certain biochemical alternations in blood and urine. J. Trace Elem. Electolytes Health Dis. 3, 123-130.
19. Fadok, V. A., Voelker, D. R., Campbell, P. A., Cohen, J. J., Bratton, D. L., and Henson P. M. (1992) Exposure of phosphatidylserine on the surface of apoptotic lymphocytes triggers specific recognition and removal by macrophages. J. Immunol. 148, 2207-2216.
20. Koopman, G., Reutelingsperger, C. P., Kuijten, G. A., Keehnen, R. M., Pals, S. T., and van Oers, M. H. (1994) Annexin V for flow cytometric detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood 84, 1415-1420.
21. Martin, S. J., Reutelingsperger, C. P., McGahon, A. J., Rader, J. A., van Schie, R. C., LaFace, D. M., and Green, D. R. (1995) Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abi. J Exp Med. 82, 1545-1556.
22. van den Eijnde, S. M., Luijsterburg, A. J., Boshart, L., De Zeeus, C. I., van Dierendonck, J. H., Reutelingsperger, C. P., and Vermeij-Keers, C. (1997) In situ detection of apoptosis during embryogenesis with annexin V: from whole mount to ultrastructure. Cytometry. 29, 313-320.
23. Chan, A., Reiter, R., Wiese, S., Fertig, G., and Gold R. (1998) Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models. Histochem. Cell Biol. 110, 553-558.
24. Clodi, K., Kliche, K. O., Zhao, S., Weidner, D., Schenk, T., Consoli, U., Jiang, S., Snell, V., and Andreeff, M. (2000) Cell-surface exposure of phosphatidylserine correlated with the stage of fludarabine-induced apoptosis in chronic lymphocytic leukemia and expression of apoptosis-regulating genes. Cytometry 40, 19-25.
25. Guo, M. F., Zhao, Y., Tian, R., Li, L., Guo, L., Xu, F., Liu, Y. M., He, Y. B., Bai, S., and Wang J. (2009) In vivo99mTc-HYNIC-annexin V imaging of early tumor apoptosis in mice after single dose irradiation. J Exp Clin Cancer Res. 28, 136-144.
26. Kaufmann, S. H., Desnoyers, S., Ottaviano, Y., Davidson, N. E., and Poirier, G. G. (1993) Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis. Cancer Res. 53, 3976-3985.
27. Jiang, C., Wang, Z., Gather, H., and Lü, J. (2001) Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells. Cancer Res. 61, 3062-3070.
28. Jiang, C., Wang, Z., Ganther, H., and Lü, J. (2002) Distinct effects of methylseleninic acid versus selenite on apoptosis, cell cycle, and protein kinase pathways in DU145 human prostate cancer cells. Mol. Cancer Ther. 1, 1059-1066.
29. Jiang, C., Kim, K. H., Wang, Z., and Lü, J. (2004) Methyl selenium-induced vascular endothelial apoptosis is executed by caspases and principally mediated by p38 MAPK pathway. Nutr. Cancer 49, 174-183.
30. Hu, H., Jiang, C., Li, G., and Lü, J. (2005) PKB/AKT and ERK regulation of caspase-mediated apoptosis by methylseleninic acid in LNCaP prostate cancer cells. Carcinogenesis 26, 1374-1381.
31. Ip, C., and Dong, Y. (2001) Methylselenocyseine modulates proliferation and apoptosis biomarkers in premalignant lesions of the rat mammary gland. Anticancer Res. 21, 863-867.
32. Bostwick, D. G., Burke, H. B., Djakiew, D., Euling, S., Ho, S. M., Landolph, J., Morrison, H., Sonawane, B., Shifflett, T., Waters, D. J., and Timms, B. (2004) Human prostate cancer risk factors. Cancer 101, 237-490.
33. Waters, D. J., and Bostwick, D. G. (1997) The canine prostate is a spontaneous model of intraepithelial neoplasia and prostate cancer progression. Anticancer Res. 17, 1467-1470.
34. Hu, H., Jiang, C., Ip, C., Rustum, Y. M., and Lü, J. (2005) Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells. Clin. Cancer Res. 11, 2379-2388.
35. Gasparian, A. V., Yao, Y. J., Lü, J., Yemelyanov, A. Y., Lyakh, L. A., Slaga, T. J., and Budunova, I. V. (2002) Selenium compounds inhibit IκB kinase (IKK) and nuclear factor-κB (NF-κB) in prostate cancer cells. Mol. Cancer Ther. 1, 1079-1087.
36. Christensen, M. J., Nartey, E. T., Hada, A. L., Legg, R. L., and Barzee, B. R. High selenium reduces NF-κB-regulated gene expression in uninduced human prostate cancer cells. Nutr. Cancer 58, 197 - 204.
37. Jüliger, S., Goenaga-Infante, H., Lister, T. A., Fitzgibbon, J., and Joel, S. P. (2007) Chemosensitization of B-cell lymphomas by methylseleninic acid involves nuclear factor-κB inhibition and the rapid generation of other selenium species. Cancer Res. 67, 10984-10992.
38. Hu, H., Li, G. X., Wang, L., Watts, J., Combs, G. F. Jr., and Lü, J. (2008) Methylseleninic acid enhances taxane drug efficacy against human prostate cancer and down-regulates antiapoptotic proteins Bcl-XL and survivin. Clin. Cancer Res. 14, 1150-1158.
39. Reagan-Shaw, S., Nihal, M., Ahsan, H., Mukhtar, H., and Ahmad, N. (2008) Combination of vitamin E and selenium causes an induction of apoptosis of human prostate cancer cells by enhancing Bax/Bcl-2 ratio. Prostate 68, 1624-1634.
40. Chun, J. Y., Hu, Y., Pinder, E., Wu, J., Li, F., and Gao, A. C. (2007) Selenium inhibition of survivin expression by preventing Sp1 binding to its promoter. Mol. Cancer Ther. 6, 2572-2580.
41. Morel, Y., and Barouki, R. (1999) Repression of gene expression by oxidative stress. Biochem. J. 342, 481-496.
42. Wang, X., Martinadale, J. L., Liu, Y., and Holbrook, N. J. (1998) The cellular response to oxidative stress: influence of mitogen-activated protein kinase signaling pathways on cell survival. Biochem. J. 333, 291-300.
43. Patel, J., McLeod, L. E., Vries, R. G. J., Flynn, A., Wang, X., and Proud, C. G. (2002) Cellular stresses profoundly inhibit protein synthesis and modulate the states of phosphorylation of multiple translation factors. Eur. J. Biochem. 269, 3076-3085.
44. Gloire, G., Legarand-Poels, S., and Piette, J. (2006) NF-κB activation by reactive oxygen species: fifteen years later. Biochem. Pharmacol. 72, 1493-1505.
45. Veal, E. A., Day, A. M., and Morgan, B. A. (2007) Hydrogen peroxide sensing and signaling. Mol. Cell 26, 1-14.
46. Sadidi, M., Lentz, S. I., and Feldman, E. L. (2009) Hydrogen peroxide-induced Akt phosphorylation regulates Bax activation. Biochimie. 91, 577-585.
47. Yamaguchi, K., Uzzo, R. G., Pimkina, J., Makhov, P., Golovine, K., Crispen, P., and Kilenko, V. M. (2005) Methylseleninic acid sensitizes prostate cancer cells to TRAIL-mediated apoptosis. Oncogene 24, 5868-5877.
48. Li, S., Zhou, Y., Dong, Y., and Ip, C. (2007) Doxorubicin and selenium cooperatively induce Fas signaling in the absence of Fas/Fas ligand interaction. Anticancer Res. 27, 3075-3082.
49. Li, Z., Carrier, L., and Rowan, B. G. (2008) Methylseleninic acid synergizes with tamoxifen to induce caspase-mediated apoptosis in breast cancer cells. Mol. Cancer Ther. 7, 3056-3063.
50. Li, G. X., Hu, H., Kiang, C., Schuster, T., and Lü, J. (2007) Differential involvement of reactive oxygen species in apoptosis induced by two classes of selenium compounds in human prostate cancer cells. Int. J. Cancer 120, 2034-2043.
51. Jiang, C., Hu, H., Malewicz, B., Wang, Z., and Lü, J. (2004) Selenite-induced p53 Ser-15 phosphorylation and caspase-mediated apoptosis in LNCaP human prostate cancer cells. Mol. Cancer Ther. 3, 877-884.